RT Journal Article
SR Electronic
T1 Characteristics and Long-term Mortality in Patients with ST-Segment Elevation Myocardial Infarction with Non-Obstructive Coronary Arteries (STE-MINOCA): A High Risk Cohort
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.02.05.23285502
DO 10.1101/2023.02.05.23285502
A1 Quesada, Odayme
A1 Yildiz, Mehmet
A1 Henry, Timothy D.
A1 Okeson, Brynn K.
A1 Chambers, Jenny
A1 Shah, Ananya
A1 Stanberry, Larissa
A1 Volpenhein, Lucas
A1 Aziz, Dalia
A1 Lantz, Rebekah
A1 Palmer, Cassady
A1 Ugwu, Justin
A1 Ahsan, Muhammad J.
A1 Garberich, Ross F.
A1 Rohm, Heather S.
A1 Aguirre, Frank V.
A1 Garcia, Santiago
A1 Sharkey, Scott W.
YR 2023
UL http://medrxiv.org/content/early/2023/02/07/2023.02.05.23285502.abstract
AB Background The prognosis of ST-segment elevation myocardial infarction with non-obstructive coronaries (STE-MINOCA) is largely unknown.Methods The objective of this study is to evaluate the prevalence, characteristics, and 5-year mortality of patients with STE-MINOCA compared to STEMI with coronary artery obstruction (STEMI-Obstruction) using a multicenter cohort of consecutive STEMI patients at 3 regional Midwest STEMI programs from 2003 to 2020. STE-MINOCA was defined based on (1) coronary stenosis < 60% by visual estimation, (2) ischemia with elevated troponin, and (3) no alternative diagnosis. STE-MINOCA was further classified based on American Heart Association (AHA) definition as AHA STE-MINOCA and AHA STE-MINOCA Mimicker.Results 8,566 STEMI patients, including 420 (4.9%) STE-MINOCA (26.9% AHA STE-MINOCA and 73.1% AHA STE-MINOCA Mimicker) were followed for a median of 7.1 years. Compared to STEMI-Obstruction, STE-MINOCA were younger, more often female, had fewer cardiovascular risk factors, and were less likely to be discharged on cardiac medications. At five years, mortality was higher in STE-MINOCA compared with STEMI-Obstruction (18% vs. 15%, p=0.033). In propensity score-matched analysis, STE-MINOCA had a 1.4-fold (95% CI: 1.04-1.89, p=0.028) higher risk of 5-year all-cause mortality compared with STEMI-Obstruction. Furthermore, 5-year mortality risk was significantly higher in AHA STE-MINOCA Mimicker (19% vs. 15%, p=0.043) but similar in AHA STE-MINOCA (17% vs. 15%, p=0.42) compared with STEMI-Obstruction.Conclusions In this large multicenter STEMI cohort, nearly 5% of patients presented with STE-MINOCA. At five years, mortality approached 20% among patients with STE-MINOCA. Despite the lower risk profile, STE-MINOCA patients were at 40% higher risk of 5-year all-cause mortality compared with STEMI-Obstruction. Additionally, 5-year all-cause mortality risk was higher in AHA STE-MINOCA Mimicker but similar in AHA STE-MINOCA compared to STEMI-Obstruction.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNIH K23 HL151867 (OQ) and Minneapolis Heart Institute FoundationAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.Not ApplicableI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Not ApplicableData openly available in a public repository that issues datasets with DOIsMINOCAMyocardial infarction with non-obstructive coronary arteriesAMIAcute myocardial infarctionSTEMIST-segment elevation myocardial infarctionSTE-MINOCAST-segment elevation myocardial infarction with non-obstructive coronary arteriesCADCoronary artery diseaseCVDCardiovascular diseaseSTEMI-ObstructionST-segment elevation myocardial infarction with coronary artery obstructionAHAAmerican Heart AssociationESCEuropean Society of CardiologyNSTEMINon-ST-segment elevation myocardial infarctionCMRCardiac magnetic resonance